Quantitative Investment Management, LLC Myriad Genetics Inc Transaction History

Quantitative Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $433,499 - $687,679	-21,762 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.16 - $19.77 $264,625 - $430,234	21,762 New	21,762 $430,000
Q2 2020 Aug 14, 2020	SELL	$10.69 - $16.49 $1.02 Million - $1.58 Million	-95,850 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.78 - $29.53 $937,412 - $2.83 Million	95,850 New	95,850 $1.37 Million
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $815,979 - $1.05 Million	-30,300 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$27.23 - $45.56 $825,069 - $1.38 Million	30,300 New	30,300 $880,000
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $2.4 Million - $3.21 Million	-63,800 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$27.75 - $40.17 $1.77 Million - $2.56 Million	63,800 New	63,800 $2.38 Million

248

91M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.02B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.